• Profile
Close

Angiogenic cytokine and interleukin 8 levels in early luteal phase after triggering ovulation with gonadotropin‐releasing hormone agonist in high‐responder patients

American Journal of Reproductive Immunology Dec 17, 2020

Martazanova B, Mishieva N, Vtorushina V, et al. - In view of the association of interleukin 8 (IL‐8), vascular endothelial growth factor A (VEGFA), its receptors 1 (VEGFR1) and 2 (VEGFR2) with ovarian hyperstimulation syndrome (OHSS) pathophysiological mechanisms, researchers here investigated the concentrations of these cytokines depending on the way of ovulation triggering. In the IVF program, 51 high‐responder patients were included. The patients received gonadotropin‐releasing hormone agonists (GnRHa) trigger + 1500 IU human chorionic gonadotropin (hCG) support on the oocyte pick‐up (OPU) day (group I), dual trigger (GnRHa + 1500 IU hCG; group II), or hCG trigger 10000 IU (group III) for the final oocyte maturation. Findings suggest that a small dose of hCG induces concentrations of VEGFA similar to a full dose of hCG, however, GnRHa triggering decreased the concentrations of VEGFR2, which could result in the OHSS prevention.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay